M. Parisien

The NCIC-Manitoba Breast Tumor Bank: a resource for applied cancer research.

P. Watson, L. Snell, M. Parisien, 1996, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Influence of Evolution in Tumor Biobanking on the Interpretation of Translational Research

Rebecca O Barnes, L. Murphy, Peter H. Watson, 2008, Cancer Epidemiology Biomarkers & Prevention.

Dynamics of breast cancer relapse reveal late recurring ER-positive genomic subgroups

Bin Liu, José Antonio Seoane Fernández, Carlos Caldas, 2019, Nature.

Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer.

Peter H Watson, Catherine Njue, L. Murphy, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

The relevance of phosphorylated forms of estrogen receptor in human breast cancer in vivo

L. Murphy, P. Watson, M. Al-Dhaheri, 2009, The Journal of Steroid Biochemistry and Molecular Biology.

Contribution de l’hôpital au traitement du patient borderline

M. Parisien, L. Morissette, 1997 .

Immunohistochemical validation of multiple phospho-specific epitopes for estrogen receptor α (ERα) in tissue microarrays of ERα positive human breast carcinomas

L. Murphy, P. Watson, M. Al-Dhaheri, 2009, Breast Cancer Research and Treatment.

Validité empirique versus validité factorielle dans les inventaires de personnalité : le MMPI-2 et les échelles restructurées RC.// Empirical validity versus factorial validity in personality inventories: The MMPI-2 and the restructured RC scales

M. Parisien, 2021, The Quantitative Methods for Psychology.

Empirical vs. factorial validity in personality inventories: The MMPI-2 and the restructured RC scales

M. Parisien, 2021, The Quantitative Methods for Psychology.